RYZEWELZI
Live / Applied — Non-final action mailed (as of 28 Sept 2026)
What this means for you
Not registered yet, but its 16 Jul 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99944009
- Mark type
- Word mark
- Filed
- 16 Jul 2026
- Attorney of record
- Xiomara Triana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, Alzheimer’s disease, autism spectrum disorder and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
Owner
- Juno Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 28 Sept 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Sept 2026 — NON-FINAL ACTION E-MAILED
- 28 Sept 2026 — NON-FINAL ACTION WRITTEN
- 25 Sept 2026 — ASSIGNED TO EXAMINER
- 16 Jul 2026 — APPLICATION FILING RECEIPT MAILED
- 16 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Jul 2026 — NEW APPLICATION ENTERED